Updated on 2025/09/10

写真a

 
Kasai Yutaka
 
Affiliation
Institute of Advanced Medical Sciences, Department of Molecular Biology, Assistant Professor
Title
Assistant Professor
External link

Research Interests

  • 細胞接着

  • がん宿主間相互作用

  • 分子間相互作用

Research Areas

  • Life Science / Tumor biology

Research History

  • Nippon Medical School   Institute for Advanced Medical Sciences

    2024.4

      More details

    Country:Japan

    researchmap

  • The University of Tokyo   The Institute of Medical Science   Assistant Professor

    2022.4 - 2024.3

      More details

    Country:Japan

    researchmap

  • The University of Tokyo   The Institute of Medical Science

    2019.4 - 2022.3

      More details

    Country:Japan

    researchmap

Professional Memberships

Papers

  • Multiple Functions of Cell Adhesion Molecule 1 (CADM1) and Its Role in the Pathogenesis of Cancer and Other Diseases.

    Yoshinori Murakami, Yutaka Kasai, Tomoko Masuda, Hiromi Ichihara, Takeshi Ito

    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi   92 ( 2 )   122 - 131   2025

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Cell adhesion molecule 1 (CADM1) is an immunoglobulin superfamily cell adhesion molecule that was first identified as a tumor suppressor in non-small cell lung cancer because of its role in suppressing tumor formation in nude mice. CADM1 forms a homophilic dimer on the cell membrane and associates with actin-binding proteins (4.1s) and scaffold proteins (MAGuKs), which contain PDZ motifs. It forms a ternary protein complex involved in cell adhesion and the formation of epithelium-like structure. While CADM1 is expressed in epithelium, neuronal tissue, and testes, CADM1 expression is absent in many cancers of epithelial origin, including cancers of the lung, esophagus, stomach, liver, pancreas, breast, and prostate. In addition to its tumor-suppressive activity in epithelial cell adhesion, CADM1 acts as a tumor antigen, recognized by activated NK cells and CD8+ T cells through heterophilic interaction with CRTAM, thereby serving as a tumor suppressor in two ways. In contrast, CADM1 is overexpressed in adult T-cell leukemia/lymphoma (ATL) cells, making it a specific diagnostic marker of ATL on FACS analysis. CADM1 is also highly expressed in small cell lung cancer (SCLC) and other neuroendocrine tumors, and promotes metastasis, suggesting its potential as a target for diagnosis and treatment of SCLC. CADM1 also has a role in synapse formation and spermatogenesis, and deficient or abnormal CADM1 is linked to disorders such as male infertility in mice and autism spectrum disorder. Here, we summarize the multiple functions of CADM1 and its involvement in cancer and other diseases, focusing on disorders of aberrant cell adhesion.

    DOI: 10.1272/jnms.JNMS.2025_92-205

    PubMed

    researchmap

  • PKR associates with 4.1R to promote anchorage-independent growth of hepatocellular carcinoma and lead to poor prognosis. International journal

    Yusuke Okujima, Takao Watanabe, Takeshi Ito, Yasumichi Inoue, Yutaka Kasai, Yusuke Imai, Yoshiko Nakamura, Mitsuhito Koizumi, Osamu Yoshida, Yoshio Tokumoto, Masashi Hirooka, Masanori Abe, Ryosuke Kawakami, Takashi Saitou, Takeshi Imamura, Yoshinori Murakami, Yoichi Hiasa

    Scientific reports   14 ( 1 )   27768 - 27768   2024.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    RNA-dependent protein kinase (PKR) may have a positive regulatory role in controlling tumor growth and progression in hepatocellular carcinoma (HCC). However, the downstream substrates and the molecular mechanism of PKR in the growth and progression of HCC have not been clarified. In this study, mass spectrometry analysis was performed with immunoprecipitated samples, and 4.1R was identified as a protein that binds to PKR. In transfected COS7 cells, an immunoprecipitation experiment showed that 4.1R binds to wild-type PKR, but not to a kinase-deficient mutant PKR, suggesting that PKR binds to 4.1R in a kinase activity-dependent manner. In HCC cell lines, HuH7 and HepG2, the expression level of 4.1R protein was shown to be regulated by protein expression and activation of PKR. Interestingly, high expression of 4.1R, as well as PKR, is associated with a worse prognosis in HCC. PKR increased HCC cell growth in both anchorage-dependent and anchorage-independent manners, whereas 4.1R was involved in HCC cell growth only in an anchorage-independent manner, not in an anchorage-dependent manner. The rescue experiment indicated that increased anchorage-independent growth of HCC cells by PKR might be caused by 4.1R. In conclusion, PKR associates with 4.1R and promotes anchorage-independent growth of HCC. The PKR-4.1R axis might be a new therapeutic target in HCC.

    DOI: 10.1038/s41598-024-75142-5

    PubMed

    researchmap

  • IGSF3 is a homophilic cell adhesion molecule that drives lung metastasis of melanoma by promoting adhesion to vascular endothelium. International journal

    Yue Guo, Yutaka Kasai, Yuto Tanaka, Yuki Ohashi-Kumagai, Takeharu Sakamoto, Takeshi Ito, Yoshinori Murakami

    Cancer science   115 ( 6 )   1936 - 1947   2024.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The immunoglobulin superfamily (IgSF) is one of the largest families of cell-surface molecules involved in various cell-cell interactions, including cancer-stromal interactions. In this study, we undertook a comprehensive RT-PCR-based screening for IgSF molecules that promote experimental lung metastasis in mice. By comparing the expression of 325 genes encoding cell-surface IgSF molecules between mouse melanoma B16 cells and its highly metastatic subline, B16F10 cells, we found that expression of the immunoglobulin superfamily member 3 gene (Igsf3) was significantly enhanced in B16F10 cells than in B16 cells. Knockdown of Igsf3 in B16F10 cells significantly reduced lung metastasis following intravenous injection into C57BL/6 mice. IGSF3 promoted adhesion of B16F10 cells to vascular endothelial cells and functioned as a homophilic cell adhesion molecule between B16F10 cells and vascular endothelial cells. Notably, the knockdown of IGSF3 in either B16F10 cells or vascular endothelial cells suppressed the transendothelial migration of B16F10 cells. Moreover, IGSF3 knockdown suppressed the extravasation of B16F10 cells into the lungs after intravenous injection. These results suggest that IGSF3 promotes the metastatic potential of B16F10 cells in the lungs by facilitating their adhesion to vascular endothelial cells.

    DOI: 10.1111/cas.16166

    PubMed

    researchmap

  • Trans-homophilic interaction of CADM1 promotes organ infiltration of T-cell lymphoma by adhesion to vascular endothelium. International journal

    Yutaka Kasai, Siew Pey Gan, Toko Funaki, Yuki Ohashi-Kumagai, Mizuki Tominaga, Shu-Jen Shiu, Daisuke Suzuki, Daisuke Matsubara, Takeharu Sakamoto, Mika Sakurai-Yageta, Takeshi Ito, Yoshinori Murakami

    Cancer science   113 ( 5 )   1669 - 1678   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The initial step of organ infiltration of malignant cells is the interaction with host vascular endothelial cells, which is often mediated by specific combinations of cell adhesion molecules. Cell adhesion molecule 1 (CADM1) is overexpressed in adult T-cell leukemia/lymphoma (ATL) and provides a cell-surface diagnostic marker. CADM1 promotes the adhesion of ATL cells to vascular endothelial cells and multiple organ infiltration in mice. However, its binding partner on host cells has not yet been identified. In this study, we show that CADM1 promotes transendothelial migration of ATL cells in addition to the adhesion to vascular endothelial cells. Moreover, CADM1 enhances liver infiltration of mouse T-cell lymphoma cells, EL4, after tail vein injection, whereas a CADM1 mutant lacking adhesive activity did not. Among the known CADM1-binding proteins expressed in primary endothelial cells, only CADM1 and CADM4 could induce morphological extension of ATL cells when plated onto glass coated with these proteins. Furthermore, CADM1-mediated liver infiltration of EL4 cells was canceled in conventional and vascular endothelium-specific Cadm1 knockout mice, whereas it was not canceled in Cadm4 knockout mice. These results suggest that CADM1 on host vascular endothelial cells is required for organ infiltration of ATL and other T-cell lymphomas expressing CADM1.

    DOI: 10.1111/cas.15307

    PubMed

    researchmap

  • Quantitative Analysis of Interaction Between CADM1 and Its Binding Cell-Surface Proteins Using Surface Plasmon Resonance Imaging. International journal

    Takeshi Ito, Yutaka Kasai, Yuki Kumagai, Daisuke Suzuki, Misaki Ochiai-Noguchi, Daisuke Irikura, Shiro Miyake, Yoshinori Murakami

    Frontiers in cell and developmental biology   6   86 - 86   2018

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The cell adhesion molecule (CADM) family of the immunoglobulin superfamily (IgSF) comprises four members, CADM1-CADM4, and participates in the formation of epithelial and synaptic adhesion through cell-cell homophilic and heterophilic interactions. To identify the partners that interact with each member of the CADM family proteins, we set up a platform for multiple detection of the extracellular protein-protein interactions using surface plasmon resonance imaging (SPRi) and analyzed the interactions between the CADM family proteins and 10 IgSF of their structurally related cell adhesion molecules. SPRi analysis identified a new interaction between CADM1 and CADM4, where this heterophilic interaction was shown to be involved in morphological spreading of adult T-cell leukemia (ATL) cells expressing CADM1 when incubated on CADM4-coated glass. Moreover, class-I MHC-restricted T-cell-associated molecule (CRTAM) was identified to show the highest affinity to CADM1 among its binding partners by comparing the dissociation constants calculated from the SPR sensorgrams. These results suggest that the SPRi platform would provide a novel screening tool to characterize extracellular protein-protein interactions among cell-surface and secreted proteins, including IgSF molecules.

    DOI: 10.3389/fcell.2018.00086

    PubMed

    researchmap

Misc.

  • VSIG4に対するNK細胞上の抑制性受容体Siglec-7の同定(Identification of Siglec-7 as an immune checkpoint receptor for VSIG4 in NK cells)

    笠井 優, 小宮 みこ, 伊東 剛, 村上 善則, 村上 善則

    日本癌学会総会記事   83回   P - 2181   2024.9

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

Research Projects

  • 細胞接着分子群の特性と体質の解明に基づくがんの新規診断、治療法の確立と意義の解明

    Grant number:24K02319  2024.4 - 2028.3

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    村上 善則, 笠井 優, 松原 大祐

      More details

    Grant amount:\16900000 ( Direct Cost: \13000000 、 Indirect Cost:\3900000 )

    researchmap

  • 表面プラズモン共鳴イメージング法を用いたがん転移促進接着分子の探索

    Grant number:23K14558  2023.4 - 2026.3

    日本学術振興会  科学研究費助成事業  若手研究

    笠井 優

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    がんによる死因の約90%は転移であり、血中循環腫瘍細胞は血管内皮細胞との相互作用を契機として転移先臓器へと浸潤する。すなわち腫瘍細胞と血管内皮細胞との相互作用を担う分子は転移のドライバーとして機能すると考えられるが、このような分子の報告はほとんどなく、これは網羅的解析手法の欠如によるものと考えられる。申請者は、表面プラズモン共鳴イメージング (SPRi) 法と独自のタンパク質ライブラリーを組み合わせることによって、腫瘍細胞と血管内皮細胞との相互作用を担う細胞外タンパク質間相互作用を網羅的に同定する系を確立した。本法はSPRiバイオチップにタンパク質ライブラリーをマイクロアレイ状に固相化し、個々のタンパク質に対するがん細胞の接着を検出することにより、細胞接着を介したがん転移促進機構を明らかにすることを目的とする。
    本年度は、タンパク質ライブラリーの拡充を図ると共に、SPRi法を用いてタンパク質ライブラリーと腫瘍細胞株との相互作用スクリーニングを行い、白血病細胞株と相互作用する複数の候補分子を得た。タンパク質ライブラリーは免疫グロブリンスーパーファミリー (IgSF) のうち細胞膜に局在する398分子種、セレクチンファミリー3分子種、インテグリンファミリー24分子種を対象とし、細胞外領域にFcを付加して精製を行った。IgSFは339/398 (85.2%)、セレクチンファミリーは3/3の精製を完了した。スクリーニングにおいて腫瘍細胞との相互作用を認めた候補分子にはこれまで転移に関する報告が無い分子が含まれた。候補分子に関して、ヒト臍帯静脈内皮細胞 (HUVEC) における発現をノックダウンし、腫瘍細胞との接着アッセイを行った結果、当該遺伝子のノックダウンによって接着が低下したことから、これらは腫瘍細胞-血管内皮細胞間の相互作用を介して転移を促進する可能性があると考えられた。

    researchmap